Verseon (LSE:VERS) Additional Paid-In Capital : £118.99 Mil(As of Jun. 2019)

View and export this data going back to 2015. Start your Free Trial

What is Verseon Additional Paid-In Capital?

Verseon's quarterly additional paid-in capital increased from Jun. 2018 (£103.92 Mil) to Dec. 2018 (£110.03 Mil) and increased from Dec. 2018 (£110.03 Mil) to Jun. 2019 (£118.99 Mil).

Verseon's annual additional paid-in capital declined from Dec. 2016 (£109.45 Mil) to Dec. 2017 (£102.62 Mil) but then increased from Dec. 2017 (£102.62 Mil) to Dec. 2018 (£110.03 Mil).

Verseon Additional Paid-In Capital Historical Data

The historical data trend for Verseon's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verseon Additional Paid-In Capital Chart

Verseon Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Additional Paid-In Capital

Get a 7-Day Free Trial

3.19

90.72

109.45

102.62

110.03

Verseon Semi-Annual Data
	Dec11	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19
Additional Paid-In Capital	Get a 7-Day Free Trial									106.84	102.62	103.92	110.03	118.99

Verseon Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Verseon Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Verseon's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Verseon (LSE:VERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verseon Corp (LSE:VERS) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

47071 Bayside Parkway, Fremont, CA, USA, 94538

Website

http://www.verseon.com

Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.